![Michelle Griffin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Griffin
Directeur/Membre du Conseil chez
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Fortune : - $ au 31/05/2026
Profil
Michelle R.
Griffin is an Independent Director at Adaptive Biotechnologies Corp.
since 2019.
Former roles include Independent Director at Acer Therapeutics, Inc. (2017–2023) and Chinook Therapeutics, Inc. (2020–2023); Chairman at Universal Cells, Inc. (2017–2018); Director at Sonus Pharmaceuticals, Inc. (2004–2008), Virginia Mason Medical Center (2014–2018), Virginia Mason Health System (2014–2018), PhaseRx, Inc. (2016–2018), Polynoma LLC (2012–2014), and Opexa Therapeutics, Inc.; Independent Director at HTG Molecular Diagnostics, Inc.; Director at Corixa Corp.
(2014–2017); Controller at Corixa Corp.
(2014–2017); Chief Financial Officer & Senior Vice President at Dendreon Corp.
(2005–2006); Chief Executive & Operating Officer, Senior VP at Emergent Product Development Seattle (2009–2010); Chief Operating Officer & Senior Vice President at Emergent Product Development Seattle (2011–2013); Chief Financial Officer & Executive VP-Operations at OncoGenex Pharmaceuticals, Inc. (2011–2013); Chief Financial Officer at Corixa Corp.
(1997–2005); Principal at Pacific Biotechnology Consulting Group (2013–2020).
Education includes undergraduate studies at George Mason University and an MBA from Seattle University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Michelle Griffin
| Sociétés | Poste | Début |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur/Membre du Conseil | 01/03/2019 |
Anciens postes connus de Michelle Griffin
| Sociétés | Poste | Fin |
|---|---|---|
| ACER THERAPEUTICS INC. | Directeur/Membre du Conseil | 17/11/2023 |
| CHINOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2023 |
Pacific Biotechnology Consulting Group
 Pacific Biotechnology Consulting Group Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biotechnology companies | Corporate Officer/Principal | 01/01/2020 |
| PHASERX, INC. | Directeur/Membre du Conseil | 01/01/2018 |
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Developing, licenses and commercializes stem cell therapies | Président | 01/01/2018 |
Formation de Michelle Griffin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and related therapies | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
HTG Molecular Diagnostics, Inc.
 HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions | Commercial Services |
Universal Cells, Inc.
Universal Cells, Inc. BiotechnologyHealth Technology Developing, licenses and commercializes stem cell therapies | Health Technology |
Virginia Mason Medical Center
 Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Provides integrated health services | Health Services |
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seattle University
 Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
PhaseRx, Inc.
 PhaseRx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures enzyme replacement therapies | Health Technology |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Polynoma LLC
 Polynoma LLC Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company that develops a novel vaccine for the adjuvant treatment of stage IIB and IIC melanoma | Health Technology |
Virginia Mason Health System
 Virginia Mason Health System Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Pacific Biotechnology Consulting Group
Pacific Biotechnology Consulting Group Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biotechnology companies | Commercial Services |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
